News
Dean
Introduction
Organization
Faculty
Research Highlights
Admission
Research Day
Location
Activity Features
National Taiwan University    |     NTU, College of Medicine
NTU, Department of Pharmacy
Graduate Institute of Clinical Pharmacy
Drug Research Center    |     Ching Kang Foundation
Center for Innovative Therapeutics Discovery
NTUH,Department of Pharmacy
Taiwan Society of Health-System Pharmacists
Alumni    |     Alumni in North America    |     AASP    |    
Instrumentation Booking System    |     Platform for Research and Inspiration in Regulatory Science
© copyright 2014 SP, NTU. All Rights Reserved.
No.33, Linsen S. Rd., Zhongzheng Dist., Taipei City 100025, Taiwan (R.O.C.)
TEL : (02)3366-8750~4    FAX : (02)2391-9098
Web person in charge: Tang-Yih Hsu
Contact Phone : (02)33668743
Latest Update : 2024 / 10 / 24
Privacy & Security Policy
Platform for Research and Inspiration in Regulatory Science
About UsResearchPublicationsNewsActivitiesContact
About Us
Sherry Ku (顧曼芹)
Current position
  • President, 顧德諮詢有限公司, Taiwan (2013-current)
Academic degree
  • Doctor of Philosophy, Major in Pharmaceutics and Pharmaceutical Chemistry, Minor in Pharmacology, College of Pharmacy, The Ohio State University, USA
  • Bachelor of Science in Pharmacy, School of Pharmacy, College of Medicine, National Taiwan University, Taiwan
Experience
  • Chairman of the Board, President, CEO Savior Lifetec Corporation, Taiwan (2014-2019)
  • President / Director of the Board, RuenHuei Biopharmaceuticals Inc., Taiwan (2012-2014)
  • President and CSO of TWi Pharmaceuticals Inc., and President of Twi Biotech, Taiwan (2010-2012)
  • Head of Early Pharmaceutical Development Department, Wyeth Inc., USA
  • Vice President, New Jersey State Pharmaceutical Association, USA
  • President, Physical Pharmacy and Biopharmaceuticals, American Association of Pharmaceutical Scientists (AAPS), USA
  • Committee Member, United States Pharmacopeial USP Convention, USA
  • Committee Member, Biotechnology Industry Strategy, Executive Yuan, Taiwan
  • Advisor, Taiwan Food and Drug Administration, Taiwan
  • Committee Member, Resident Companies Application Review Committee, BioHub Taiwan, National Biotechnology Research Park, Academia Sinica, Taiwan
  • Advisor, Ministry of Economic Affairs, Taiwan
  • Advisor, Biotechnology Development Center & Drug Commercialization Center
  • Counselor, Institute of Biomedical Sciences, Academia Sinica, Taiwan
  • Director, Biochemical Technology Education Foundation
  • Director, Taiwan Pharmaceutical Manufacture and Development Association
Achievement
  • Developed more than 170 new drugs, with 85 Investigational New Drug (IND) applications and 9 listed drugs, including Suprax, Zosyn/Tazocin, Zebeta, Isovorin, Thioplex, Sonata, Tygacil, Bosutinib, and Neratinib in Wyeth/Pfizer.
  • Completed 6 Abbreviated New Drug Application (ANDA), including 3 Paragraph IV application, and 6 new drug developments, including 3 biologics, within the 18-month working period in TWi Pharmaceuticals Inc.
  • Meropenem and Ertapenem injection global product licenses in US ANDA / EU MA in Savior Lifetec Corporation.
Research subjects
  • Pharmaceutical Market Research
  • Regulatory Filing in the US and EU
  • Clinical Drug Research
  • Clinical Pharmacology
  • Preclinical Drug Development
  • Pharmacology and Toxicology
  • Pharmacokinetics and Drug Metabolism
  • Physical Pharmacy and Biopharmaceuticals
  • Bioavailability Enhancement
  • Crystallinity, Polymorphism and Salt Selection
  • Analytical and Bioanalytical Method Development
  • Quality Control and Quality Assurance
For further information available on request (Email: kus_98@yahoo.com)